Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2024-05-29
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of Impella RP Support System in Patients With Right Heart Failure
NCT01777607
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
NCT03242642
CentriMag RVAS U.S. Post-approval Study Protocol
NCT01568424
Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study
NCT03635424
Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study
NCT03022708
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients implanted with right-sided ventricular assist device
Right-sided ventricular assist device
Percutaneous device for right heart support
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Right-sided ventricular assist device
Percutaneous device for right heart support
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abiomed Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Pima Heart and Vascular
Tucson, Arizona, United States
Baptist Health Heart Failure and Transplant Institute
Little Rock, Arkansas, United States
Arkansas Heart Hospital
Little Rock, Arkansas, United States
University of Southern California (Keck USC)
Los Angeles, California, United States
Advent Health Orlando
Orlando, Florida, United States
Tampa General
Tampa, Florida, United States
Ochsner Clinic Foundation
New Orleans, Louisiana, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Henry Ford Hospital
Detroit, Michigan, United States
Ascension St. John Hospital
Detroit, Michigan, United States
Metropolitan Heart and Vascular Institute
Coon Rapids, Minnesota, United States
Providence St. Patrick Hospital
Missoula, Montana, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
Northwell Health/Lenox Hill Hospital
New York, New York, United States
Montefiore Medical Center - Moses
The Bronx, New York, United States
Novant Health New Hanover Regional Medical Center
Wilmington, North Carolina, United States
Wake Forest University School of Medicine
Winston-Salem, North Carolina, United States
The Lindner Research Center at the Christ Hospital
Cincinnati, Ohio, United States
Providence St. Vincent Medical Center
Portland, Oregon, United States
Legacy Research Institute (Legacy Emanuel Medical Center)
Portland, Oregon, United States
Oregon Health and Science System
Portland, Oregon, United States
UPMC Presbyterian
Pittsburgh, Pennsylvania, United States
Medical City Heart Hospital Dallas
Dallas, Texas, United States
Baylor University Medical Center
Dallas, Texas, United States
Memorial Herman Texas Medical Center
Houston, Texas, United States
The Heart Hospital Baylor Plano
Plano, Texas, United States
MultiCare Institute for Research Innovation
Puyallup, Washington, United States
Providence Sacred Heart Medical Center
Spokane, Washington, United States
Froedtert Hospital (Medical College of Wisconsin)
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Impella RP Flex Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.